This opportunity is no longer accepting applications.
grant PAR-23-131

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

This grant aims to support research that advances precision medicine and improves drug safety and effectiveness for pregnant and lactating individuals, fetuses, neonates, and children, including those with disabilities. It focuses on developing new tools and technologies, understanding drug actions and physiological changes during pregnancy and lactation, and creating or improving therapeutic …

The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clin…

Funding Source

Agency: National Institutes of Health
Sub-agency: <em>Eunice Kennedy Shriver</em> National Institute of Child Health and Human Development
Program: SBIR

Awards & funding

Award Ceiling: $225,000
Award Amount: $225,000

Dates

Open for Submission: March 1, 2023
Submission Deadline: May 7, 2026
Application Window Closes: May 7, 2026
Opportunity Released: March 1, 2023

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.